One product appeared to come from a 'research use only' vendor called AlphaLabs. Harvard's Pieter Cohen urges the FDA to investigate; Public Citizen counts at least 14 hospitalizations.
Recap by typeshit. Full story at New York Post.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
His talk covers losing fat while keeping muscle on GLP-1 drugs, and it opens the festival's Harmony in Health series.
NewsNation reports FDA inspectors found mold at Chinese plants supplying compounded GLP-1 drugs, a fresh safety flag for anyone using cheaper copies.
Loading…